Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
99 studies found for:    "Sclerosis" AND (woman OR women OR female)
Show Display Options
Rank Status Study
21 Terminated Treating Multiple Sclerosis With Sirolimus, an Immune System Suppressor
Condition: Multiple Sclerosis (MS) - Relapsing-remitting
Intervention: Biological: sirolimus
22 Completed Effect of Fasting on the Size of Abdominal Lymphatic Tumors in Women
Conditions: Lymphangioleiomyomas;   Tuberous Sclerosis;   Lymphangioleiomyomatosis
Intervention:
23 Recruiting Study of the Disease Process of Lymphangioleiomyomatosis
Conditions: Lung Disease;   Pneumothorax;   Tuberous Sclerosis
Intervention:
24 Completed The Efficacy of Vitamin K2 n Human Osteoporosis, Blood-vessel Calcification and Sclerosis
Condition: Healthy
Interventions: Dietary Supplement: Vit K2+ Vit D3+ calcium carbonate (CaCO3);   Dietary Supplement: Vit K2+CaCO3
25 Unknown  Effects of Spinal Cord Injury on Female Sexual Response
Conditions: Female Sexual Dysfunction;   Multiple Sclerosis;   Spinal Cord Injury
Intervention: Procedure: Sympathetic manipulation on sexual arousal in women
26 Completed ATP Expression in Lymphocytes of MS Patients by Means of "ImmuKnow®" Assay.
Condition: Multiple Sclerosis
Intervention:
27 Active, not recruiting An Efficacy and Safety Study of BG00012 (Dimethyl Fumarate) in Asian Subjects With Relapsing Remitting Multiple Sclerosis (RRMS)
Conditions: Relapsing-Remitting Multiple Sclerosis;   Multiple Sclerosis
Interventions: Drug: Placebo;   Drug: dimethyl fumarate
28 Completed Phase 3 Study of Dexpramipexole in ALS
Condition: Amyotrophic Lateral Sclerosis
Interventions: Drug: Dexpramipexole;   Drug: Placebo
29 Terminated Phase 3 Extension Study of Dexpramipexole in ALS
Condition: Amyotrophic Lateral Sclerosis
Intervention: Drug: Dexpramipexole
30 Completed Success of Titration, Analgesics, and B.E.T.A Nurse Support on Acceptance Rates in Early Multiple Sclerosis (MS) Treatment With Betaseron
Conditions: Multiple Sclerosis;   Multiple Sclerosis, Relapsing-Remitting
Intervention: Drug: Interferon-1beta (Betaseron, BAY86-5046)
31 Completed The Effect of Sildenafil Citrate (Viagra® (Registered Trademark)) on Brain Blood Flow in Multiple Sclerosis Patients
Condition: Multiple Sclerosis
Intervention:
32 Completed Safety and Efficacy of Natalizumab in Combination With Avonex in the Treatment of Multiple Sclerosis
Condition: Multiple Sclerosis, Relapsing-Remitting
Interventions: Drug: Natalizumab;   Drug: Placebo
33 Completed
Has Results
Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study Two
Condition: Multiple Sclerosis, Relapsing-Remitting
Interventions: Biological: Alemtuzumab 12 mg;   Biological: Alemtuzumab 24 mg;   Biological: Interferon beta-1a
34 Completed Observational Study for Assessment of the Effect of Fampyra on the Manual Function of Persons With Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention:
35 Recruiting Biogen Multiple Sclerosis Pregnancy Exposure Registry
Conditions: Multiple Sclerosis;   Exposure During Pregnancy
Interventions: Drug: dimethyl fumarate;   Drug: Peginterferon beta-1a;   Drug: Dalclizumab High Yield Process
36 Recruiting Cervical Spinal Cord Metabolism and Microstructure in Amyotrophic Lateral Sclerosis(ALS)
Condition: Amyotrophic Lateral Sclerosis
Intervention: Procedure: Amyotrophic Lateral Sclerosis
37 Completed Safety and Efficacy of Natalizumab in the Treatment of Multiple Sclerosis
Condition: Multiple Sclerosis, Relapsing-Remitting
Interventions: Drug: Natalizumab;   Drug: Placebo
38 Completed A Study to Assess the Relative Bioavailability of Different Formulations of GSK2018682, a Sphingosine-1-phosphate Receptor Subtype 1 Agonist, in Healthy Volunteers.
Condition: Multiple Sclerosis, Relapsing-Remitting
Intervention: Drug: GSK2018682 CD2 Capsule; GSK2018682 CD3 non-micronised Tablet; GSK2018682 CD3 micronised Tablet; GSK2018682 CD3 non-micronised Tablet in fed state
39 Recruiting Pregnancy Registry Trial
Condition: Multiple Sclerosis
Intervention: Drug: Fingolimod
40 Enrolling by invitation Outpatient Hematopoietic Grafting in Multiple Sclerosis Employing Autologous Peripheral Blood Stem Cells
Condition: Multiple Sclerosis
Intervention: Procedure: Hematopoietic stem cell transplantation

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years